Record #24385

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

Institution
Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China · Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA · Department of Neurosurgery, The First Hospital, China Medical University, Shenyang, Liaoning, China · Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia · Department of Animal Science, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, Republic of Korea · Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany. Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA. Synactix Pharmaceuticals Inc., Tucson, Arizona, USA. Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, East China Normal University, Shanghai, China. Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Department of Health Science and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Department of Psychiatry, David Geffen School of Medicine, UCLA, Los Angeles, California, USA · Department of Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California, USA · Department of Pediatrics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
Open access
No
Article type
Notes from Retraction Watch

see also: https://pubpeer.com/publications/09034E8E74FB303771B0ECCD26EF83

Citation lifecycle

How this paper is being cited

Pre-retraction
41
Same day
1
Post-retraction
33
% post-retraction
44.0%
~13.2 citations/yr before retraction · ~5.5 citations/yr after
citing papers

Who is still citing this work

Loading…